Walgreens Boots Alliance Inc (NASDAQ:WBA) announced a quarterly dividend on Friday, January 19th, Wall Street Journal reports. Stockholders of record on Thursday, February 15th will be given a dividend of 0.40 per share by the pharmacy operator on Monday, March 12th. This represents a $1.60 annualized dividend and a dividend yield of 2.09%. The ex-dividend date is Wednesday, February 14th.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at $76.47 on Friday. The stock has a market capitalization of $75,290.84, a P/E ratio of 21.12, a PEG ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance has a one year low of $63.82 and a one year high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period last year, the company earned $1.10 EPS. sell-side analysts predict that Walgreens Boots Alliance will post 5.71 earnings per share for the current fiscal year.
Several equities research analysts have recently issued reports on WBA shares. Jefferies Group reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, October 26th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $88.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, October 25th. Mizuho set a $94.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, October 24th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. Nine equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $86.20.
In other news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The shares were purchased at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.
WARNING: This story was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://stocknewstimes.com/2018/01/20/walgreens-boots-alliance-inc-declares-quarterly-dividend-of-0-40-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.